Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a maintenance update to the study record page. No substantive study content or participant information changes are evident in the provided context.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a platform version update. No user-facing study content changes are evident.SummaryDifference0.0%

- Check56 days agoChange DetectedThis change updates the page's revision label from v3.6.0 to v3.6.3. It signals a minor behind-the-scenes update rather than a modification to the study details or user-facing content.SummaryDifference0.0%

- Check70 days agoChange DetectedRecruitment status now shows that enrollment is closed, and new guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added. Minor header formatting changes and a version update to v3.6.0 (replacing v3.5.5) are also included.SummaryDifference0.4%

- Check77 days agoChange DetectedThe page now displays Revision: v3.5.5 in place of Revision: v3.5.4, indicating an update to the site revision rather than content changes.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a small update to the entry version.SummaryDifference0.0%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.